# Immune Tolerance Induction After Liver Transplantation

> **NCT07269041** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 12 (estimated)

## Conditions studied

- Liver Transplantation
- Immune Tolerance
- Immune Tolerance/Drug Effects
- Graft Survival
- Hematopoietic Stem Cell
- Chimerism
- Immunosuppression After Liver Transplantation
- Immunosuppression Disorders
- End Stage Liver Disease

## Interventions

- **BIOLOGICAL:** Donor Hematopoietic Stem and Progenitor Cell Infusion

## Key facts

- **NCT ID:** NCT07269041
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-20
- **Primary completion:** 2029-01
- **Final completion:** 2033-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269041, "Immune Tolerance Induction After Liver Transplantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07269041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*